Guangzhou Medical University

This trial is testing a combination of the immunotherapy drug tislelizumab plus two chemotherapy drugs (albumin-bound paclitaxel and a platinum agent) in 30 people with a specific type of lung cancer called KRAS-mutant non-small cell lung cancer. The participants have advanced or…

This study tests a new treatment for leptomeningeal metastasis, a condition where cancer spreads to the lining of the brain and spinal cord. The treatment combines an immune checkpoint inhibitor (a drug that helps the immune system fight cancer) with pemetrexed (a chemotherapy dr…

This study is testing whether an artificial intelligence model can more accurately diagnose the cause of severe pneumonia compared to traditional methods. Researchers will collect data from 1,000 ICU patients, including medical images, lab tests, and immune system information. Th…